Please enable JS

ARTICLES & PRESS RELEASES

FILTER BY TYPE

Most Recent

Categories

ARCHIVES

Aimovig®: A Cautious New Hope

Aug 07/Jamie Sanders/ Migraine

By now, just about every migraine patient has heard about Aimovig® (erenumab), the first FDA approved treatment for the prevention of migraine in episodic and chronic patients. The news was announced on May 17, 2018 and I’m sure there was a resounding cheer from migraine patients all across the country. Aimovig® is a member of […]

READ MORE

Have You Tried…? Some Of The Worst Things You Can Say To A Migraine Patient

May 16/Jaime Sanders / Migraine

It feels like migraine patients have been given remedies, cures and suggestions that will help them since the beginning of time. Most of the time these “tips” are things we have already tried, or simply old wives’ tales passed down from someone’s uncle’s cousin’s great-grandmother. I asked my closest migraine friends and advocates to share […]

READ MORE

10 Things Migraine Advocates Wish the World Knew About Migraine

Apr 12/GHLF Staff / Migraine

  The absolute number one thing we wish the world knew about migraine is that it is NOT a headache. Headache is one of several disabling symptoms of migraine, which is a serious and debilitating neurological disease affecting over almost 40 million men, women and children in the United States and over 1 billion worldwide.1 […]

READ MORE

Acetaminophen Overdoses More Common During Flu Season, Study Finds

Mar 19/GHLF Staff / Uncategorized

During flu and cold season, patients are nearly 25 percent likelier to take too much of the over-the-counter painkiller acetaminophen — one of whose brand names is Tylenol, and which is an ingredient in hundreds of medications — than they are the rest of the year. That’s what researchers found when they studied 14,481 patients […]

READ MORE

FDA approves evolocumab for strokes, heart attacks

Dec 11/GHLF Staff / Cardiovascular

On Dec. 1, the U.S. Food and Drug Administration approved the PCSK9 inhibitor evolocumab (Repatha) to prevent heart attacks and strokes. It is the first PCSK9 approved for these conditions in adults with cardiovascular disease, notes Amgen in a release. Many patients, who had already been receiving the best therapies available, remained at high risk […]

READ MORE